HU163631B - - Google Patents

Info

Publication number
HU163631B
HU163631B HUSU616A HUSU000616A HU163631B HU 163631 B HU163631 B HU 163631B HU SU616 A HUSU616 A HU SU616A HU SU000616 A HUSU000616 A HU SU000616A HU 163631 B HU163631 B HU 163631B
Authority
HU
Hungary
Application number
HUSU616A
Other languages
Hungarian (hu)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed filed Critical
Publication of HU163631B publication Critical patent/HU163631B/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24Oxygen atoms
    • C07D243/26Preparation from compounds already containing the benzodiazepine skeleton
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24Oxygen atoms
    • C07D243/28Preparation including building-up the benzodiazepine skeleton from compounds containing no hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/06Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
    • C07D243/10Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
    • C07D243/141,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
    • C07D243/161,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
    • C07D243/181,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
    • C07D243/24Oxygen atoms
    • C07D243/30Preparation including building-up the benzodiazepine skeleton from compounds already containing hetero rings
    • C07D243/32Preparation including building-up the benzodiazepine skeleton from compounds already containing hetero rings containing a phthalimide or hydrogenated phthalimide ring system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HUSU616A 1970-04-23 1971-04-23 HU163631B (cg-RX-API-DMAC7.html)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP45035735A JPS494226B1 (cg-RX-API-DMAC7.html) 1970-04-23 1970-04-23

Publications (1)

Publication Number Publication Date
HU163631B true HU163631B (cg-RX-API-DMAC7.html) 1973-09-27

Family

ID=12450072

Family Applications (1)

Application Number Title Priority Date Filing Date
HUSU616A HU163631B (cg-RX-API-DMAC7.html) 1970-04-23 1971-04-23

Country Status (6)

Country Link
JP (1) JPS494226B1 (cg-RX-API-DMAC7.html)
AT (1) AT302315B (cg-RX-API-DMAC7.html)
CH (1) CH559730A5 (cg-RX-API-DMAC7.html)
CS (1) CS167310B2 (cg-RX-API-DMAC7.html)
HU (1) HU163631B (cg-RX-API-DMAC7.html)
ZA (1) ZA712391B (cg-RX-API-DMAC7.html)

Also Published As

Publication number Publication date
CH559730A5 (en) 1975-03-14
JPS494226B1 (cg-RX-API-DMAC7.html) 1974-01-31
CS167310B2 (cg-RX-API-DMAC7.html) 1976-04-29
AT302315B (de) 1972-10-10
ZA712391B (en) 1972-01-26

Similar Documents

Publication Publication Date Title
AR204384A1 (cg-RX-API-DMAC7.html)
ATA96471A (cg-RX-API-DMAC7.html)
AU2044470A (cg-RX-API-DMAC7.html)
AU1146470A (cg-RX-API-DMAC7.html)
AU1473870A (cg-RX-API-DMAC7.html)
AU2085370A (cg-RX-API-DMAC7.html)
AU1336970A (cg-RX-API-DMAC7.html)
AU2130570A (cg-RX-API-DMAC7.html)
AU2017870A (cg-RX-API-DMAC7.html)
AU1833270A (cg-RX-API-DMAC7.html)
AU1716970A (cg-RX-API-DMAC7.html)
AU1517670A (cg-RX-API-DMAC7.html)
AU1326870A (cg-RX-API-DMAC7.html)
AR195465A1 (cg-RX-API-DMAC7.html)
AU1591370A (cg-RX-API-DMAC7.html)
AU1841070A (cg-RX-API-DMAC7.html)
AU1328670A (cg-RX-API-DMAC7.html)
AU2144270A (cg-RX-API-DMAC7.html)
AU1343870A (cg-RX-API-DMAC7.html)
AU1277070A (cg-RX-API-DMAC7.html)
AU2131570A (cg-RX-API-DMAC7.html)
AU2130770A (cg-RX-API-DMAC7.html)
AU1247570A (cg-RX-API-DMAC7.html)
AU1581370A (cg-RX-API-DMAC7.html)
AU1235770A (cg-RX-API-DMAC7.html)